Insight

Nazli Dizman: ICI rechallenge and future directions in mRCC

Photo taken from Nazli Dizman/X

May 21, 2024, 07:30

Nazli Dizman: ICI rechallenge and future directions in mRCC

Nazli Dizman, a Hematology/Oncology Fellow at MD Anderson Cancer Center, shared a post by The American Society of Clinical Oncology (ASCO) on X, adding:

“Check out our ASCO Daily News article on ICI rechallenge and future directions in mRCC with Toni Choueiri, Emre Yekedüz, and Marc Machaalani.

Really appreciate ASCO for this opportunity.”

Quoting ASCO’s post:

“For ASCO Daily News Toni Choueiri, Nazli Dizman, Marc Machaalani, andEmre Yekedüz examine recent/ongoing research efforts exploring IO rechallenge after prior ICI exposure to understand its potential in mRCC.”

mRCC

Additional information.
Source: Nazli Dizman/X and ASCO/X

ASCO ASCO Daily News cancer Emre Yekedüz ICI exposure ICI rechallenge ith Toni Choueiri Marc Machaalani MD Anderson Cancer Center mRCC Nazli Dizman OncoDaily Oncology the American Society of Clinical Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage